Healthcare Equipment and Supplies
Company Overview of NinePoint Medical, Inc.
NinePoint Medical, Inc., a transformational medical device company, develops in vivo pathology medical devices. Its proprietary Nvision VLE Imaging System focuses on enabling physicians and pathologists to view real-time, high-resolution, and volumetric images of organs and tissues. The company focuses on devices that enable real-time, endoscopic screening, and surveillance of diseases of the mucosa of various tissues that are precancerous. NinePoint Medical was incorporated in 2008 and is based in Cambridge, Massachusetts.
One Kendall Square
Cambridge, MA 02139
Founded in 2008
Key Executives for NinePoint Medical, Inc.
Senior Director of Manufacturing/Operations
Senior Director of Business Development and Strategic Planning
Vice President of Research and Development
Senior Director of Engineering and Program Management
Compensation as of Fiscal Year 2014.
NinePoint Medical, Inc. Key Developments
NinePoint Medical, Inc. Announces Addition of Three New Members to its Board of Directors
Mar 20 14
NinePoint Medical, Inc. announced it has completed a $34 million Series B financing led by Corning Incorporated along with Third Rock Ventures and Prospect Venture Partners. The company also announced the addition of three new members to its board of directors: Curt Weinstein from Corning, and independent directors Tom Miller and Mark Stautberg. Further expanding the expertise on the board of directors, Mr. Miller has previously held senior positions with Siemens, Carl Zeiss, Analogic Corporation and LightLab Imaging, and brings a wealth of international operating experience to NinePoint's board of directors. Mr. Stautberg joins NinePoint's board with more than 30 years of medical device sales and marketing experience from Boston Scientific Corporation and Baxter Healthcare, and currently serves as a director on the board of Baxano Surgical.
NinePoint Medical, Inc. Announces U.S. Commercial Availability of the NvisionVLE(TM) Imaging System
May 16 13
NinePoint Medical, Inc. announced the commercial launch of its proprietary NvisionVLE(TM) Imaging System in the United States. In addition, NinePoint announced the launch of its newly redesigned website, www.ninepointmedical.com. In December 2011, the NvisionVLE Imaging System received 510(k) clearance from the U.S. Food and Drug Administration for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross sectional, real-time depth visualization. Last month, NinePoint received 510(k) clearance to expand the System's indication to include imaging of esophageal tissue microstructure. Originally developed at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH), NinePoint licensed the imaging technology from MGH in 2010 as part of the intellectual property agreement for medical device technology in the hospital's history. The NvisionVLE Imaging System enables physicians and pathologists to endoscopically view real-time, high-resolution, cross sectional images of organs and tissues up to 3mm deep at better than 10 micron resolution.
NinePoint Medical, Inc. Receives Additional FDA 510(K) Clearance for NvisionVLE Imaging System
Apr 26 13
NinePoint Medical, Inc. announced that it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NvisionVLE(TM) Imaging System, expanding the system's indication to include imaging of esophageal tissue microstructure. In January 2012, the company announced 510(k) clearance from the FDA to market its NvisionVLE Imaging System for use as an imaging tool in the evaluation of human tissue microstructure by providing two-dimensional, cross sectional, real-time depth visualization.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 3, 2014